G. Celine Han PhD

Celine Han is a computational biologist and research investigator in Analytics Innovation, Oncology Translational Bioinformatics at Bristol-Myers Squibb (BMS). Her focus of research is to identify data gaps and to bring in innovative data and methods to inform decision-making for drug development through integration and analysis of patient molecular and clinical data from clinical trials and real-world data (RWD). Her work involves driving and leading complex collaborations and communications with commercial and academic partners, computational and experimental scientists, physicians, and information technologists.

Prior to joining BMS, she completed her postdoctoral training at Harvard Medical School, Dana-Farber Cancer Institute and Broad Institute of MIT and Harvard in Dr. Eliezer Van Allen's lab. She studied the responses and resistance to androgen deprivation therapy for patient stratification and prioritization of combined therapies in metastatic prostate cancer. She completed her Ph.D. training in Bioinformatics and Genomics at Pennsylvania State University studying epigenetics and transcriptional regulation in erythropoiesis by examining binding locations of transcription factors. Celine also received her Bachelor of Science degree in Life Science at Pennsylvania State University.